| 0.2 |
1.5 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
0.9 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 |
0.7 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.2 |
0.6 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.2 |
0.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.7 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.9 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.5 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.1 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) |
| 0.1 |
0.1 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.1 |
0.3 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
1.9 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.7 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.3 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
0.2 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.1 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.2 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.5 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.2 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.2 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
0.4 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 |
0.2 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.1 |
0.6 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.3 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.2 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.1 |
0.2 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.1 |
0.2 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.2 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.1 |
0.2 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.0 |
0.1 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.0 |
0.2 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.0 |
0.2 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.0 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.0 |
0.1 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.0 |
1.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.2 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.0 |
0.1 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.0 |
0.4 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.0 |
0.2 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.0 |
0.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.7 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.3 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.2 |
GO:0021784 |
postganglionic parasympathetic fiber development(GO:0021784) |
| 0.0 |
0.0 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.2 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.1 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.0 |
0.2 |
GO:0099540 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 |
0.1 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.0 |
0.3 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.0 |
0.1 |
GO:0045356 |
positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.0 |
0.3 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.0 |
0.1 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.0 |
0.1 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.0 |
0.1 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.0 |
0.1 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.0 |
0.2 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.0 |
0.0 |
GO:1900086 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.0 |
0.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.0 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.2 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.0 |
0.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
1.0 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.0 |
0.3 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.0 |
0.0 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.0 |
0.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.0 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.0 |
0.3 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.0 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 |
0.1 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.0 |
0.2 |
GO:0071105 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.0 |
0.1 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.0 |
0.1 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.0 |
0.1 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 |
0.3 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 |
0.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.0 |
0.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 |
0.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.1 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.0 |
0.1 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.2 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.1 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) |
| 0.0 |
0.0 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.0 |
0.4 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.0 |
0.1 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 |
0.2 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.0 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.0 |
0.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.0 |
0.2 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.1 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.0 |
0.1 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.0 |
0.1 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) female genitalia morphogenesis(GO:0048807) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.0 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.0 |
0.1 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
0.2 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.1 |
GO:0035711 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.0 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.0 |
0.0 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.0 |
0.1 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.0 |
0.0 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.0 |
0.1 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.0 |
0.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.0 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.0 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.9 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.4 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.0 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.1 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 |
0.1 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.0 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 |
0.1 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.2 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) |
| 0.0 |
0.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.0 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.0 |
0.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.1 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.4 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.1 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.0 |
0.0 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.1 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.0 |
0.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.0 |
0.1 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.0 |
1.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.1 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.4 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 |
0.1 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.0 |
0.1 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.0 |
0.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.1 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.0 |
0.2 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.0 |
0.1 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.0 |
0.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.0 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.1 |
GO:0006833 |
water transport(GO:0006833) |
| 0.0 |
0.0 |
GO:0090294 |
nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) histone H3-R17 methylation(GO:0034971) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.0 |
0.4 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.0 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.0 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.0 |
0.1 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.2 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.0 |
0.1 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.1 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:1901563 |
cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.1 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.0 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.0 |
0.1 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.0 |
0.0 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.0 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.0 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.0 |
0.0 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.0 |
0.1 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.0 |
0.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.1 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
| 0.0 |
0.0 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.0 |
0.3 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.0 |
0.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.1 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.0 |
0.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.0 |
0.0 |
GO:0045799 |
positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.0 |
0.0 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.0 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 |
0.1 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.1 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.0 |
0.3 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.0 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.0 |
0.1 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.0 |
0.1 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 |
0.1 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.1 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.2 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.0 |
0.2 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.2 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.0 |
0.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.1 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.0 |
0.3 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.0 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.0 |
0.2 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 |
0.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.0 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.0 |
0.0 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.0 |
0.0 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.0 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 |
0.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.0 |
GO:1901624 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.0 |
0.1 |
GO:1903115 |
regulation of actin filament-based movement(GO:1903115) |
| 0.0 |
0.0 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 |
0.0 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.0 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.0 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 |
0.0 |
GO:0001808 |
negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.0 |
0.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.2 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 |
0.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.2 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.0 |
0.1 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.0 |
0.0 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.0 |
0.1 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.1 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.0 |
0.3 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.0 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.0 |
0.2 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0045007 |
depurination(GO:0045007) |
| 0.0 |
0.0 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
